StreetAlpha.app
Home › Stocks › DGX

Quest Diagnostics Inc (DGX)

Healthcare
$256.42
▼ −2.26%
LAST CLOSE · NOV 17

Quest Diagnostics provides laboratory testing and diagnostic information services to physicians, hospitals, patients and consumers. It last closed at $256.42 on Nov 17, down 2.26% on the day. DGX reports earnings on Tue, Feb 9, 2027. The average 12-month price target from 3 analysts is $255.00 (-0.6% from the last close), with a high of $260.00 and a low of $245.00. Analyst consensus is Hold, based on the latest ratings from 3 firms (1 buy, 2 hold, 0 sell). In the past 30 days there were 4 dark pool prints totaling $2.7M, the largest $929K.

AI Auto Pilots
Is DGX in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$11.8B
+9.1% vs a year ago
Net income
$1.1B
+16.5% vs a year ago
EPS (diluted)
$10.04
+17.8% vs a year ago
Free cash flow
$1.4B
11.6% margin
Valuation
Market cap
$28.2B
110.0M shares
P/E
25.5
Price over 12 month EPS
Price to sales
2.4
Market cap over revenue
Dividend yield
1.32%
$3.38 a share over 12 months
Balance sheet
Cash & equivalents
$797.0M
At Sep 30
Debt
$5.5B
At Sep 30
Shareholder equity
$7.6B
Buybacks
$552.0M
Last 12 months
CEOSteve Rusckowski
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $10.8B$10.8BFY2021FY2022: $9.9B$9.9BFY2022FY2023: $9.3B$9.3BFY2023FY2024: $9.9B$9.9BFY2024FY2025: $11.0B$11.0BFY2025

From DGX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 23). Last 12 months adds up the four latest quarters.

Next report
Feb 9
2027 · Time not announced
Consensus EPS forecast
$2.68
$3.04B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
3firms
1 Buy2 Hold0 Sell
Each firm's latest rating on DGX in the past 90 days
Average 12-month target
$255.00
▼ 0.6% downside

Based on 3 analysts who set a price target on DGX in the past 90 days. The average target is $255.00, with a high of $260.00 and a low of $245.00, compared with the last close of $256.42.

Low $245.00Avg $255.00High $260.00
Blue marker: last close $256.42
Highest target$260.00
Average target$255.00
Lowest target$245.00
Latest rating changes
BarclaysTarget raised
Oct 7Buy$250 → $260
Truist SecuritiesTarget raised
Sep 21Hold$250 → $260
UBSTarget raised
Sep 8Hold$232 → $245
JP MorganMaintained
Jul 28Hold$250
UBSMaintained
Jul 25Hold$232
DateFirmActionRatingPrice target
Oct 7BarclaysTarget raisedBuy$250 → $260
Sep 21Truist SecuritiesTarget raisedHold$250 → $260
Sep 8UBSTarget raisedHold$232 → $245
Jul 28JP MorganMaintainedHold$250
Jul 25UBSMaintainedHold$232
Loading…

Technical Analysis

DGX · as of the Nov 17 close · updated after every close
Uptrend

The stock is 2% above its 20 day and 6% above its 50 day average. It is 16% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 60). The nearest support is the Pivot S1 at $254.04, and the nearest resistance the swing high (Oct 30) at $256.99.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 2.2%/day
Key levels
$263.1952 week high+2.6%
$260.87Pivot R1+1.7%
$258.49Pivot+0.8%
$256.99Swing high (Oct 30)+0.2%
$256.42Last close
$254.04Pivot S1−0.9%
$251.9320 day average−1.8%
$244.58Swing low (Nov 3)−4.6%
$242.2250 day average−5.5%
$235.14100 day average−8.3%
$216.44200 day average−15.6%
$171.1852 week low−33.2%
Indicators
RSI (14)59.71Middle of its rangeNeutral
MACD5.70Above its signal lineBullish
Stochastic83.4Near the top of its rangeOverbought
ADX (14)20.5Weak trend
Williams %R-36.4Oversold below −80, overbought above −20Neutral
CCI (20)72.0Oversold below −100, overbought above 100Neutral
Rate of change+3.8%Change over 10 sessionsBullish
ATR (14)$5.63Typical daily range, 2.2% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for DGX

What happened before

See how DGX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow DGX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How DGX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in DGX in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
4
Notional
$2.7M
Largest print
$929K
Loading…

DGX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●494 buying vs 490 selling
  • ▼Held by funds -2.4 pts
  • ▲Funds holding +22
  • ●Superinvestors: 2 added, 2 cut
  • ▼Put/call 0.81 to 7.91
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,1371,115+2.0%
In funds' top 10330.0%
Held by funds93.3%95.7%−2.4 pts
New / increased124 / 370108 / 428−7.8%
Reduced / sold out401 / 89353 / 70+15.8%
Put/call ratio7.910.81+870.6%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DGX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

DGX Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$552.0M
2.0% yield
Left in program
$1.2B
4.2% of value
Shares outstanding, 12 months
−1.1%
Fewer shares
Last quarter
$305.5M
Sep 2026
Avg price paid, last quarter
$238.95
1.3M shares bought
S&P 500 rank by spending
#265 of 358
 
Spent each quarter, last 3 yearsTop bar $603.4M
Dec 2023: $552.4M, average price $135.95Mar 2024: $46.3M, average price $125.56Jun 2024: $391K, average price $143.16Sep 2024: $1.3M, average price $143.75Dec 2024: $300.2M, average price $159.00Mar 2025: $83.6M, average price $172.91Jun 2025: $1.2M, average price $176.42Sep 2025: $302.0M, average price $176.07Dec 2025: $603.4M, average price $183.21Mar 2026: $74.4M, average price $206.02Jun 2026: $201.0M, average price $191.40Sep 2026: $305.5M, average price $238.95
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 23, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DGX is in one of them and how their past DGX trades turned out.

DGX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DGX in an article yet. Here's the latest on the wider market.

DGX Congress Trades

All congress trades →
Trades, 12 months
14
Buys
8
57%
Sells
6
43%
People
6
Last filed Nov 5
Who traded DGX · since 2019
Latest 5 filings of 56
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$15K – $50KTraded Jul 23, 2026Filed Sep 22, 2026
$15K – $50KTraded Mar 10, 2025Filed Aug 14, 2026
$1K – $15KTraded Oct 30, 2025Filed Aug 5, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d
Donald J TrumpExecutive branchSell$15K – $50KJul 23, 2026Sep 22, 202661 d
Carol Devine MillerR · WVSell$15K – $50KMar 10, 2025Aug 14, 2026522 d
Julie JohnsonD · TXBuy$1K – $15KOct 30, 2025Aug 5, 2026279 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Quest Diagnostics

Quest Diagnostics provides medical laboratory testing and diagnostic information services from its headquarters in Secaucus, New Jersey. Its test menu covers a wide range of tests, and it also offers insights drawn from its lab results. Its main customers are physicians, hospitals, patients and consumers, and it also serves health plans, employers, government agencies and pharmaceutical companies. Quest operates patient service centers, many inside retail stores, and an online platform where consumers can order tests directly.

Headquarters
Secaucus, NJ
Founded
1967